PET-CT Scanner Device Market Share, Size, Trends, Industry Analysis Report, By Application (Cardiology, Oncology, Neurology); By End-Use (Hospital, Research Institute, Diagnostic Center, Ambulatory Surgical Centers); By Type; By Modality; By Slice Count; By Detector Type; By Region; Segment Forecast, 2021 - 2028

Report Summary

The global PET-CT scanner device market size was valued at USD 2.03 billion in 2020 and is anticipated to grow at a CAGR of 6.6% during the forecast period. The product provides imaging of anatomy and metabolic function within the body in a single scan. It is non-invasive, requires no downtime afterward, and enables differentiation between a cancerous and noncancerous mass.

Know more about this report:请求样本页面

该产品越来越多地用于检测癌症，评估治疗的有效性，预后评估，弱心肌肌肉，脑异常分析，以及组织代谢和可行性的评估。慢性病的发生，慢性病的发生，并根据政府和私营机构在制定先进的医疗保健设备的发展中纳入扫描以及越来越多的投资是预计在预测期间促进对产品的需求的因素。betway体育亚洲版入口

PET-CT device is a combination of positron emission tomography (PET) detectors and computed tomography (CT). The PET-CT scanner devices combine the metabolic data from the scan with the detailed anatomic data from theCT扫描设备提供高度详细的图像。扫描仪使用放射性葡萄糖，其注入静脉以检测肿瘤细胞，其消耗比正常细胞更多的葡萄糖。

行业动态

成长司机
The product offers improved patient outcomes offering high accuracy in diagnoses. These products also assist in developing improved targeted treatment plans, and less-invasive treatment monitoring. PET-CT scanner devices offer enhanced patient comfort by reducing scan time and the number of scanning sessions.

Technological advancements and significant investments in research and development support market growth. New product launches and acquisitions by leading players in the market have increased the demand for the product across the globe. In August 2019, United Imaging announced the first installation of its uExplorer total-body PET-CT system.

uExplorer is a result of collaboration between United Imaging and the Explorer Consortium. uExplorer requires 20 to 30 seconds for total-body imaging in a single bed position. uExplorer enables continuous tracking of tracer distribution in blood, organs, and tissues at high speed and efficiency. It also assists and supports pharmacokinetic studies and radiation dose evaluation.

In October 2019, GE Healthcare collaborated with Theragnostics for the development of a prostate-specific membrane antigen (PSMA) imaging agent. GalliProst, which is a tracer for the detection of prostate cancer is being developed by Theranostics. GE Healthcare is responsible for pre-approval commercial preparations, and commercial and distribution activities.

新的示踪剂使得能够产生呈现前列腺癌细胞的精确定位和强度的热映射样式图像。通过增加中国，日本和印度等国家的需求，增加了全球市场，不断增长的老年人，以及医疗保健支出上升。betway体育亚洲版入口全球参与者正在扩展到发展中国家，以挖掘市场潜力，进一步推动市场增长。

PET-CT Scanner Device Market Report Scope

该市场主要基于类型，模当，应用，最终用途，切片计数，探测器类型和区域进行分段。

按类型	通过方式	By Application	通过最终用户	通过切片计数	By Detector Type	By Region
数字的 Analog	固定的 移动的	心脏病学 Oncology 神经病学 其他	医院 研究机构 Diagnostic Center 步Surgical Centers 其他	高切片 中等切片 低切片	铊 氟化钠18℃ Fluorodeoxyglucose FMISO. 62cu atsm. 镓 其他	North America (U.S., Canada) 欧洲（德国，英国，法国，意大利，西班牙，獐鹿） 亚太地区（中国，印度，日本，韩国，罗阿普克） Latin America (Brazil, Mexico, Colombia, RoLATAM) MEA (Saudi Arabia, South Africa, Israel, UAE, RoMEA)

Know more about this report:请求样本页面

类型Outlook.

在类型的基础上，市场被分段为数字和模拟。在预测期间，预计对数字市场的需求将增加。数字扫描仪配备有固态传感器，该固态传感器能够在扫描过程中计算单个闪烁光子。这些扫描仪提高了图像的质量，从而提高了检测病变的机会，同时降低扫描时间。

模态前景

基于模态，市场被分段为固定和移动。由于更高的可靠性和提高效率，固定PET-CT扫描仪设备段在2020年为PET-CT扫描仪设备提供全球市场。固定PET-CT扫描仪设备增强了患者体验。增加的老年人口，改变生活方式和生长发生的肿瘤学和心脏病学障碍的越来越多地增加了对医院的固定PET-CT扫描仪设备的需求。

应用前景

肿瘤段在2020年为PET-CT扫描仪设备提供全球市场.PET-CT扫描结合了CT扫描和PET扫描以提供更准确的结果。PET扫描使用温和的放射性药物来突出具有更高细胞活性的身体区域。PET-CT扫描仪设备用于检测和诊断癌症的癌症，肿瘤的大小和所需的处理。

宠物扫描提供了使用低水平辐射的体现身体的代谢和生化活动的图像，而来自设备的CT扫描负责证明各种病变的位置，尺寸和形状的详细信息并创建3D图片。

End-Use Outlook

在最终用途的基础上，市场被分段为医院，研究机构，诊断中心，守护手术中心等。医院段在2020年为PET-CT扫描仪设备的全球市场主导了。高交通环境，高级医疗保健基础设施，先进医疗设备的可用性以及越来越多的诊断成像程序驱动了该段的增长。betway体育亚洲版入口增加在技术先进的医疗设备发展方面的投资，更需要提供改善的患者护理，并且越来越多的采用微创手术进一步燃料的增长。betway体育亚洲版入口

切片计数前景

该市场被分段为高切片扫描仪，中式切片扫描仪，基于切片计数的低切片扫描仪。中型切片扫描仪段在2020年主导了全局PET-CT扫描仪设备市场。由于其提供了软组织结构的尺寸，形状和位置的增强视图，所以中型切片扫描仪被广泛使用。这些扫描仪也用于鉴定肿瘤和囊肿，以及检测肝，肺和冠状动脉等的疾病。

区域前景

North America dominated the global market for PET-CT scanner device in 2020. The increasing geriatric population, growing research and development activities, and technological advancements are some factors attributed to the growth of this regional segment. There have been increasing incidences of chronic diseases registered in the region, driving the growth of this region. Rising health concerns established healthcare infrastructure, and growing awareness regarding preventive healthcare and early diagnosis of diseases has increased the demand for PET-CT scanner devices in the region.

竞争格局

The leading players in the PET-CT scanner device market include General Electric Co., Mediso Ltd., Toshiba Corporation, Siemens AG, Positron Corporation, Shimadzu Corporation, Perkin Elmer Inc., Fujifilm Holdings, Koninklijke Philips N.V., Carestream, ECHO-SON S.A., Hitachi Ltd., Fonar Corporation, Esaote S.P.A., and Yangzhou Kindsway Biotech Co. Ltd.